Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
09/2009
09/03/2009WO2009072835A3 Transgenic cats expressing red fluorescence protein and producing method thereof
09/03/2009US20090222955 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils
09/03/2009US20090222938 Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases
09/03/2009US20090222937 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof
09/03/2009US20090222936 Recombinant Expression of Multiprotein Complexes Using Polygenes
09/03/2009US20090222935 Transgenic animals and uses thereof
09/03/2009US20090222934 gene overexpression; lymphoproliferative diseases; drug screening
09/03/2009US20090222933 Human Liver Cancer Cell Line
09/03/2009US20090222932 Alzheimer's disease animal model, method for obtaining same and uses thereof
09/03/2009US20090222931 Novel identified oncogene with kinase-domain (nok)
09/03/2009US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals
09/03/2009US20090221035 Systems and methods for protein production
09/03/2009US20090220494 Antibodies produced in a transgenic avian
09/03/2009US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
09/03/2009US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease
09/03/2009US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
09/03/2009US20090220470 Ubiquitin binding polypeptides
09/03/2009US20090220466 Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
09/02/2009EP2096172A2 Genetic sequences having methyltransferase activity and uses therefor
09/02/2009EP2096120A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
09/02/2009EP2094847A2 Inhibition of gpr4
09/02/2009CN201299049Y Worm encroaching regulation inspection box suitable for tobacco warehouses
09/02/2009CN201299048Y Culturing container for pet turtles
09/02/2009CN201299047Y Special intensification cage for feeding python
09/02/2009CN201299046Y Simplified fowl inseminating syringe
09/02/2009CN101519664A Method for breeding genetically modified animal by using recombinant adenovirus vector
09/02/2009CN101519443A Method for inducing silkworms to produce antibacterial peptides by radiation or electric shock
09/02/2009CN101519442A Method for inducing silkworms to produce antibacterial peptides
09/02/2009CN101518219A Apparatus for magnetic suspension culture of aquatic organisms
09/02/2009CN101518218A Comprehensive method for ecological pig cultivation
09/02/2009CN101518216A Method for seed production of O.mossambicus and O.hornorum
09/01/2009US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
09/01/2009US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders
09/01/2009US7582440 Imaging, diagnosis and treatment of disease
08/2009
08/27/2009WO2009105244A1 Recombiant non-human mammalian model for hepatitis infection and immunopathogenesis
08/27/2009WO2009104794A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification
08/27/2009WO2009104730A1 Identification of hypertension susceptibility gene group
08/27/2009WO2009104053A2 Composition and method to modify sperm function and increase male gender ratio in mammals
08/27/2009WO2009103978A2 Biological materials and uses thereof
08/27/2009US20090217404 Cell-based RNA interference and related methods and compositions
08/27/2009US20090217403 Means and methods for generating a t cell against an antigen of interest
08/27/2009US20090217402 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
08/27/2009US20090217401 Human Monoclonal Antibodies To Programmed Death 1(PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone or in Combination with Other Immunotherapeutics
08/27/2009US20090217400 Enzymes, cells and methods for site specific recombination at asymmetric sites
08/27/2009US20090217399 Lentiviral Vectors That Provide Improved Expression And Reduced Variegation After Transgenesis
08/27/2009US20090217398 Methods to identify fat and lean animals using class predictors
08/27/2009US20090217397 Cre-lox based gene knockdown constructs and methods of use thereof
08/27/2009US20090217396 Inflammation models in neurodegenerative and arthritic disorders
08/27/2009US20090217395 Promoter Mutations that Increase Amyloid Precursor Protein Expression
08/27/2009US20090217394 Diabetes Model Animal
08/27/2009US20090217393 Growth Promoting Agent and Life Prolonging Agent
08/27/2009US20090217391 T1r3 a novel taste receptor
08/27/2009US20090217390 Non-human animal sarcoma model
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215680 Inhibitor peptides
08/27/2009US20090215672 Cys-Rich, Cell Surface Glycoproteins
08/27/2009US20090214548 TGR3-Like Protein Receptor
08/27/2009US20090214519 Compositions and Methods for Treating Inflammation
08/27/2009US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue
08/27/2009US20090214482 Transgenic Mammals Expressing Human Preproinsulin
08/27/2009CA2701170A1 Composition and method to modify sperm function and increase male gender ratio in mammals
08/26/2009EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/26/2009EP2093293A2 G-Protein coupled receptors
08/26/2009EP2093289A1 Knockout animal exhibiting anxiety-like behavior
08/26/2009EP2093280A1 Cre-master mouse (mouse strain selectively lacking mast cells)
08/26/2009EP1734814A4 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
08/26/2009EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells
08/26/2009EP1066324B1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions
08/26/2009CN201294810Y Parasitoid chouioia cunea releaser
08/26/2009CN101517407A An animal model for studying atherosclerotic lesions
08/26/2009CN101517071A Meganuclease variants cleaving a DNA target sequence from a RAG gene and uses thereof
08/26/2009CN101514356A Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
08/26/2009CN101514350A High-efficiency ecological recycling system of maize straw and technological process
08/26/2009CN101513176A Raising method of phyllotreta striolata experimental population
08/26/2009CN101513159A Elephant grass and methane
08/26/2009CN100532547C Polyploid breeding method for inducing heterogenous tripoid scallop by physical means
08/25/2009US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry
08/25/2009US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family
08/25/2009US7579328 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
08/25/2009CA2368217C Bacterial cell component-unresponsive model mouse
08/20/2009WO2009101939A1 Non-human mammal model of epilepsy
08/20/2009WO2009077618A3 A host cell deficient for murf1 and murf2
08/20/2009US20090210956 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure
08/20/2009US20090210955 Shrna and sirna expression in a living organism under control of a codon-optimized repressor gene
08/20/2009US20090210954 Genes
08/20/2009US20090210953 Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release
08/20/2009US20090210952 Compositions and Methods Related to Controlled Gene Expression Using Viral Vectors
08/20/2009US20090210950 Methods for screening for agents that affect development
08/20/2009US20090210949 Method of ameliorating symptom caused by mood disturbance
08/20/2009US20090209045 Screening assay
08/20/2009US20090208537 Anti-Neovasculature Preparations for Cancer
08/20/2009US20090208516 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
08/20/2009US20090208504 Polypeptides involved in immune response
08/20/2009US20090208503 Immunotherapeutic treatment
08/20/2009US20090208501 Anti-Pathogen Immunoadhesins
08/20/2009US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions
08/20/2009US20090208419 Multimodality Imaging of Reporter Gene Expression Using a Novel Fusion Vector in Living Cells and Animals
08/19/2009EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses
08/19/2009EP2088854A1 Improved xenogenic immune system in a non-human mammal
08/19/2009EP1778858A4 High throughput pharmaceutical screening using drosophila